Novel inflammation-based model for postoperative early recurrence prediction of hepatitis B virus-related hepatocellular carcinoma ≤ 5 cm

Figure 3 Construction and evaluation of an inflammation-related score-based nomogram for predicting the early recurrence of hepatitis B virus-related hepatocellular carcinoma ≤ 5 cm in the training cohort. A: The inflammation-related score-based nomogram for 1-, and 2-year recurrence-free survival (RFS) prediction of hepatocellular carcinoma (HCC) patients; B: Calibration curves of the nomogram for prediction of the early RFS of HCC patients; C: Receiver operating characteristic curves of the nomogram and other parameters and staging systems for discrimination evaluation of the early RFS of HCC patients; D and E: Decision analysis curves for beneficial evaluation of the nomogram and other parameters and staging systems for early RFS of HCC patients. RFS: Recurrence-free survival; IRS: Inflammation-related score; AUC: Areas under the curve; MVI: Microvascular invasion; BCLC: Barcelona Clinic Liver Cancer; TNM: Tumor-node-metastasis; CNLC: China Liver Cancer.